Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon May 31, 2023 8:40am
164 Views
Post# 35471949

RE:Light at the end of the Tunnel

RE:Light at the end of the Tunnel

I hear ya...

but...

I am not in favour of adding 50-100m shares at low prices either. 

The story is too good, the opportunity too immense, and the need too great. 

Where is the media story? The reach out to the analyst community? The all important US investor ( 10X the population, 25X the appetite for these type of stocks) 

Any listing upgrade must be accompanied by the willingness and the capability to tell the story. 

It's a fallacy that all reverse splits result in a decline in market cap. When you magnify the potential demand by 25 and you are already at a rock bottom MC to begin with, you have only one direction to move ( hint: it's not down) 

To do nothing is to allow "late to the game" buyers to take advantage and steal future profits ( ie upside) from loyal long-timers who are unable or unwilling to invest/ tie-up more capital ( something option and other "goodie" recipients are not required to do) 

Time to lower the cost of capital unless Baxter is ready willing and able to accelerate funding in the short term. 

MM 

<< Previous
Bullboard Posts
Next >>